Patient Guide: A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 0 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07459738
Status: NOT_YET_RECRUITING
Condition: Hormone Receptor Positive HER-2 Negative Breast Cancer
Phase: PHASE2

Loading interactive enrollment tools...

The full interactive experience will load momentarily